Literature DB >> 19467771

Perioperative morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a European multicentre experience.

M Pilar Laguna1, Patricia Beemster, Vivenkanandar Kumar, Patricia Kumar, H Christoph Klingler, Stephen Wyler, Chris Anderson, Francis X Keeley, Alexander Bachmann, Jorge Rioja, Charalampos Mamoulakis, Michael Marberger, Jean J de la Rosette.   

Abstract

BACKGROUND: Low morbidity has been advocated for cryoablation of small renal masses.
OBJECTIVES: To assess negative perioperative outcomes of laparoscopic renal cryoablation (LRC) with ultrathin cryoprobes and patient, tumour, and operative risk factors for their development. DESIGN, SETTING, AND PARTICIPANTS: Prospective collection of data on LRC in five centres. INTERVENTION: LRC. MEASUREMENTS: Preoperative morbidity was assessed clinically and the American Society of Anaesthesiologists (ASA) score was assigned prospectively. Charlson Comorbidity Index (CCI) and Charlson-Age Comorbidity Index (CACI) scores were retrospectively assigned. Negative outcomes were prospectively recorded and defined as any undesired event during the perioperative period, including complications, with the latter classed according to the Clavien system. Patient, tumour, and operative variables were tested in univariate analysis as risk factors for occurrence of negative outcomes. Significant variables (p<0.05) were entered in a step-forward multivariate logistic regression model to identify independent risk factors for one or more perioperative negative outcomes. The confidence interval was settled at 95%. RESULTS AND LIMITATIONS: There were 148 procedures in 144 patients. Median age and tumour size were 70.5 yr (range: 32-87) and 2.6 cm (range: 1.0-5.6), respectively. A laparoscopic approach was used in 145 cases (98%). Median ASA, CCI, and CACI scores were 2 (range: 1-3), 2 (range: 0-7), and 4 (range: 0-11), respectively. Comorbidities were present in 79% of patients. Thirty negative outcomes and 28 complications occurred in 25 (17%) and 23 (15.5%) cases, respectively. Only 20% of all complications were Clavien grade > or = 3. Multivariate analysis showed that tumour size in centimetres, the presence of cardiac conditions, and female gender were independent predictors of negative perioperative outcomes occurrence. Receiver operator characteristic curve confirmed the tumour size cut-off of 3.4 cm as an adequate predictor of negative outcomes.
CONCLUSIONS: Perioperative negative outcomes and complications occur in 17% and 15.5%, respectively, of cases treated by LRC with multiple ultrathin needles. Most of the complications are Clavien grade 1 or 2. The presence of cardiac conditions, female gender, and tumour size are independent prognostic factors for the occurrence of a perioperative negative outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19467771     DOI: 10.1016/j.eururo.2009.05.002

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  12 in total

Review 1.  Management of small renal masses: a review.

Authors:  Mesut Remzi; Elchin Javadli; Mehmet Ozsoy
Journal:  World J Urol       Date:  2010-02-23       Impact factor: 4.226

Review 2.  Non-Surgical Ablative Therapy for Management of Small Renal Masses-Current Status and Future Trends.

Authors:  K Farrag; S Sriprasad
Journal:  Indian J Surg Oncol       Date:  2016-12-15

3.  Surgical cryoablation as an option for small renal masses in patients who are not ideal partial nephrectomy candidates: intermediate-term outcomes.

Authors:  Venu Chalasani; Carlos H Martinez; Darwin Lim; Mazen Abdelhady; Joseph L Chin
Journal:  Can Urol Assoc J       Date:  2010-12       Impact factor: 1.862

4.  CT-guided percutaneous cryoablation of renal masses in selected patients.

Authors:  C Spreafico; N Nicolai; R Lanocita; C Morosi; M Catanzaro; E Civelli; T Torelli; S Stagni; L Piva; L F Frigerio; A Marchianò; R Salvioni
Journal:  Radiol Med       Date:  2011-10-21       Impact factor: 3.469

5.  Percutaneous renal cryoablation complicated by hemorrhage.

Authors:  Jeffrey Critchfield; Joe Harb
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

Review 6.  The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation.

Authors:  Tobias Klatte; Nils Kroeger; Uwe Zimmermann; Martin Burchardt; Arie S Belldegrun; Allan J Pantuck
Journal:  World J Urol       Date:  2014-04-04       Impact factor: 4.226

7.  The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate.

Authors:  Charalampos Mamoulakis; Ioannis Efthimiou; Savas Kazoulis; Ioannis Christoulakis; Frank Sofras
Journal:  World J Urol       Date:  2010-05-12       Impact factor: 4.226

Review 8.  Management of small renal masses--update 2011.

Authors:  C Surcel; C Mirvald; C Gingu; R Stoica; I Sinescu
Journal:  J Med Life       Date:  2011-05-25

9.  Renal cryoablation of small renal masses: a Korea University experience.

Authors:  Hyung Keun Kim; Jong Hyun Pyun; Jae Yoon Kim; Seung Bin Kim; Seok Cho; Sung Gu Kang; Jeong Gu Lee; Je Jong Kim; Jun Cheon; Seok Ho Kang
Journal:  Korean J Urol       Date:  2015-02-02

10.  BioGlue surgical adhesive as a thermal reflector during laparoscopic cryoablation: effect on iceball size and ablation zone diameter.

Authors:  Adam C Mues; Phillip Mucksavage; Joseph A Graversen; Jaime Landman
Journal:  JSLS       Date:  2012 Jan-Mar       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.